Inclusion Criteria:
  -  Patients with (suspicion of) primary or recurrent EOC with an indication for surgery, chemotherapy and/or immunotherapy.
  -  Age â‰¥18 years.
  -  WHO performance status 0-2.
  -  Accessible for treatment and follow-up.
  -  Written informed consent.
Exclusion Criteria:
  -  Other active malignancy in past 5 years prior to entry into the study, except for treated non-melanoma skin cancer.
  -  Any known severe infection like HIV, hepatitis A, B and C.
  -  Receiving immune suppressive treatment.
  -  Medical or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or sign meaningful informed consent.